ZENVIA INC - A (ZENV)

KYG9889V1014 - Common Stock

1.34  +0.11 (+8.94%)

Premarket: 1.34 0 (0%)

Fundamental Rating

2

Overall ZENV gets a fundamental rating of 2 out of 10. We evaluated ZENV against 279 industry peers in the Software industry. Both the profitability and financial health of ZENV have multiple concerns. ZENV is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year ZENV has reported negative net income.
ZENV had a positive operating cash flow in the past year.
ZENV had negative earnings in 4 of the past 5 years.
ZENV had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

ZENV's Return On Assets of -6.47% is in line compared to the rest of the industry. ZENV outperforms 44.80% of its industry peers.
ZENV has a Return On Equity (-14.08%) which is in line with its industry peers.
Industry RankSector Rank
ROA -6.47%
ROE -14.08%
ROIC N/A
ROA(3y)-6.48%
ROA(5y)-3.73%
ROE(3y)-12.02%
ROE(5y)-8.14%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 39.67%, ZENV is doing worse than 76.34% of the companies in the same industry.
In the last couple of years the Gross Margin of ZENV has grown nicely.
ZENV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.22%
GM growth 5Y4.61%

1

2. Health

2.1 Basic Checks

ZENV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZENV has more shares outstanding
ZENV has a better debt/assets ratio than last year.

2.2 Solvency

ZENV has an Altman-Z score of 0.37. This is a bad value and indicates that ZENV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.37, ZENV is doing worse than 71.33% of the companies in the same industry.
ZENV has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.07, ZENV perfoms like the industry average, outperforming 54.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACC19.42%

2.3 Liquidity

ZENV has a Current Ratio of 0.49. This is a bad value and indicates that ZENV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.49, ZENV is not doing good in the industry: 93.19% of the companies in the same industry are doing better.
A Quick Ratio of 0.49 indicates that ZENV may have some problems paying its short term obligations.
The Quick ratio of ZENV (0.49) is worse than 92.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.49

6

3. Growth

3.1 Past

ZENV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.15%, which is quite impressive.
The Revenue has grown by 20.93% in the past year. This is a very strong growth!
Measured over the past years, ZENV shows a very strong growth in Revenue. The Revenue has been growing by 23.92% on average per year.
EPS 1Y (TTM)49.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.17%
Revenue 1Y (TTM)20.93%
Revenue growth 3Y23.41%
Revenue growth 5Y23.92%
Sales Q2Q%19.83%

3.2 Future

ZENV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.88% yearly.
The Revenue is expected to grow by 12.13% on average over the next years. This is quite good.
EPS Next Y13.04%
EPS Next 2Y47.26%
EPS Next 3Y36.88%
EPS Next 5YN/A
Revenue Next Year16.29%
Revenue Next 2Y12.74%
Revenue Next 3Y12.13%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZENV. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 51.09 indicates a quite expensive valuation of ZENV.
The rest of the industry has a similar Price/Forward Earnings ratio as ZENV.
ZENV's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.56.
Industry RankSector Rank
PE N/A
Fwd PE 51.09

4.2 Price Multiples

97.49% of the companies in the same industry are more expensive than ZENV, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.58

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZENV does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ZENV's earnings are expected to grow with 36.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.26%
EPS Next 3Y36.88%

0

5. Dividend

5.1 Amount

ZENV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZENVIA INC - A

NASDAQ:ZENV (11/20/2024, 8:00:02 PM)

Premarket: 1.34 0 (0%)

1.34

+0.11 (+8.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap69.51M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 51.09
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.47%
ROE -14.08%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 39.67%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.49
Quick Ratio 0.49
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)49.15%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y13.04%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)20.93%
Revenue growth 3Y23.41%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y